Brain Cooling with TMS for Healthy Subjects
Trial Summary
Yes, you will need to stop taking certain medications. The trial excludes participants who are taking medications such as antidepressants, anxiolytics (anti-anxiety drugs), anticonvulsants (anti-seizure drugs), antipsychotics, antiparkinson drugs, hypnotics (sleep aids), stimulants, and antihistamines.
Research shows that Theta Burst Stimulation (TBS), a type of Transcranial Magnetic Stimulation (TMS), is effective in treating depression and is more energy- and time-efficient than standard repetitive TMS. Additionally, TBS has been studied for its effects on brain activity and recovery in stroke patients, suggesting its potential benefits in modulating brain function.
12345Transcranial Magnetic Stimulation (TMS) and its variations, like Repetitive TMS (rTMS) and Theta Burst Stimulation (TBS), have been studied for safety. Most adverse effects are mild, but there is a small risk of seizures, especially with high-frequency protocols like TBS. Safety guidelines exist to minimize these risks, and TMS is generally considered safe when applied with caution.
678910Brain cooling with TMS is unique because it combines transcranial magnetic stimulation (TMS), which uses magnetic pulses to stimulate the brain, with a cooling technique to manage heat generated during the process, potentially enhancing the treatment's effectiveness and duration.
1112131415Eligibility Criteria
This trial is for healthy, right-handed adults aged 18-35 who can lie flat on their back for up to an hour. Participants must not have psychiatric conditions, be pregnant, or have a history of neurological disorders. They should not take certain medications and must abstain from caffeine and tobacco before visits.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Main Study Treatment
Participants undergo cooling and TMS procedures to study the effects of cooling on brain plasticity
Sub-study Treatment
Participants undergo EEG phase-triggered paired associative stimulation (PAS) to optimize TMS delivery
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
Transcranial Magnetic Stimulation (TMS) is already approved in United States, European Union for the following indications:
- Major Depressive Disorder (MDD)
- Obsessive-Compulsive Disorder (OCD)
- Migraine Headache Symptoms
- Major Depressive Disorder (MDD)
- Obsessive-Compulsive Disorder (OCD)